|
Tel 0571 568 147 Fax 0571 568 132 vb@vincibiochem.it |
 |
Histone Deacetylases (HDAC) & Histone Acetyltransferase (HAT)
Eukaryotic DNA is highly organized and packaged into the nucleus. The organization and packaging are achieved through the addition of proteins, including core histones H2A, H2B, H3 and H4, which form a complex structure, the chromatin, together with DNA. The modification of core histones is of fundamental importance to conformational changes of the chromatin. The level of acetylation is related to transcription activity, and then the acetylation induces an open chromatin confirmation that allows the transcription machinery access to promoters. Histone deacetylase (HDAC) and histone acetyltransferase (HAT) are enzymes that influence transcription by selectively deacetylating or acetylating the ε-amino groups of lysine located near the amino termini of core histone proteins. Chromatin acetylation correlates with transcriptional activity (euchromatin), whereas deacetylation correlates with gene silencing. HDACs are also involved in the reversible acetylation of non-histone proteins. Altered HDAC and/or HAT activities are present in many types of cancers.
Mammalian HDACs have been classified into three classes. Class I (HDACs 1, 2, 3 & 8; each of which contains a deacetylase domain exhibiting from 45% to 93% identity in amino acid sequence) are homologs of yeast RPD3 and localize to the nucleus. Class II (HDACs 4, 5, 6, 7, 9 & 10) are homologs of yeast Hda1 and are found in both the nucleus and cytoplasm. The molecular weights of which are all about twofold larger than those of the class I members, and the deacetylase domains are present within the C-terminal regions, except that HDAC-6 contains two copies of the domain, one within each of the N-terminal and C-terminal regions. HDAC11 has properties of both class I and class II HDACs. Class III (Sirt1 - Sirt7) are homologs of yeast Sir2 and form a structurally distinct class of NAD-dependent enzymes found in both the nucleus and cytoplasm.
Conserved from yeast to human, HDAC classes I and II are inhibited by trichostatin A (Prod. No. 380-068) and appear to use a divalent zinc-binding motif. The metal-coordinated active site activates an H2O molecule for direct targeting and hydrolysis of the acetyl group to form acetate. Acetylation of lysines in histones neutralizes the positive electric charge between the negatively charged DNA backbone and tips the balance towards relaxing the chromatin, while deacetylation would shift the balance back to condensing the chromatin and silencing gene expression. In a similar way PARP-1 adds to histones hundreds of negatively charged ADP-ribose units, which repel histones away from the negatively charged DNA backbone and thus induces chromatin relaxation to facilitate accession of DNA repair enzymes and gene expression.
Unlike HDAC classes I and II, Sir2-like proteins catalyze a unique reaction, that like PARP-1, requires the coenzyme NAD+. In this reaction, nicotinamide is liberated from NAD+ and the acetyl group of the substrate is transferred to cleaved NAD+, generating the novel metabolite O-acetyl-ADP ribose. Due to the NAD+ dependency, Sir2 might be the link between metabolic activity and genome stability and, finally, aging.
Inhibitors of HDAC classes I and II emerge as potent anti-cancer agents. A proposed mechanism for the anti-tumor effects of HDAC inhibitors is that the accumulation of acetylated histones leads to activation (and repression) of the transcription of a selected number of genes whose expression causes inhibition of tumor cell growth and induction of apoptosis.
Disruption of HDACs has been linked to a wide variety of human cancers. HDAC inhibitors have been shown to be potent inducers of growth arrest, differentiation, and/or apoptotic cell death. Some newly synthesized compounds are potentially effective agents for cancer therapy and, possibly, cancer chemoprevention.
Disruption of HDACs has been linked to a wide variety of human cancers. HDAC inhibitors have been shown to be potent inducers of growth arrest, differentiation, and/or apoptotic cell death. Some newly synthesized compounds are potentially effective agents for cancer therapy and, possibly, cancer
chemoprevention.
|
HDAC Inhibitors |
|
|
|
Apicidin [cyclo-L-(2-Amino-8-oxodecanoyl)-L-(N-methoxy-tryptophan)-L-isoleucyl-D-pipecolinyl] |
ALX-350-095-M001 |
1 mg |
|
|
ALX-350-095-M005 |
5 mg |
|
5-Aza-2'-deoxycytidine |
ALX-480-096-M005 |
5 mg |
| CAY10398 | CAY-89740-M001 | 1 mg |
| CAY-89740-M005 | 5 mg | |
| CAY-89740-M010 | 10 mg | |
| CAY-89740-M050 | 50 mg | |
| CAY10433 | CAY-10005019-M001 | 1 mg |
| CAY-10005019-M005 | 5 mg | |
| CAY-10005019-M010 | 10 mg | |
| CAY-10005019-M050 | 50 mg | |
|
6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide |
ALX-270-437-M001 |
1 mg |
|
HC Toxin |
ALX-630-102-M001 |
1 mg |
|
ITSA1 |
ALX-270-382-M005 |
5 mg |
|
|
ALX-270-382-M025 |
25 mg |
|
M344 |
ALX-270-297-M001 |
1 mg |
|
|
ALX-270-297-M005 |
5 mg |
|
MC 1293 |
ALX-270-344-M005 |
5 mg |
|
MS-275 |
ALX-270-378-M001 |
1 mg |
|
|
ALX-270-378-M005 |
5 mg |
|
|
ALX-270-378-M025 |
25 mg |
|
Oxamflatin |
ALX-270-379-M001 |
1 mg |
|
|
ALX-270-379-M005 |
5 mg |
| PXD101 | CAY-10004279 | |
| SAHA (Discontinued) | ||
|
Scriptaid |
ALX-270-298-M001 |
1 mg |
|
|
ALX-270-298-M005 |
5 mg |
|
Sirtinol |
ALX-270-308-M001 |
1 mg |
|
|
ALX-270-308-M005 |
5 mg |
|
Sodium butyrate |
ALX-270-301-G001 |
1 g |
|
Sodium 4-phenylbutyrate |
ALX-270-303-M100 |
100 mg |
| Splitomicin | ALX-270-380-M001 | 1 mg |
| ALX-270-380-M005 | 5 mg | |
|
|
ALX-270-380-M025 |
25 mg |
|
Trichostatin A |
ALX-380-068-M001 |
1 mg |
|
|
ALX-380-068-M005 |
5 mg |
|
Trichostatin A |
CAY-89730-C500 |
500 g |
|
|
CAY-89730-M001 |
1 mg |
|
|
CAY-89730-M005 |
5 mg |
|
|
CAY-89730-M010 |
10 mg |
|
Valproic acid . sodium salt |
ALX-550-304-G005 |
5 g |
|
|
|
|
|
Histone Deacetylase (HDAC) Fluorescent Substrate |
|
|
|
Histone Deacetylase Substrate (Fluorometric) |
ALX-260-137-M001 |
1 mg |
|
|
ALX-260-137-M005 |
5 mg |
| Fluorogenic HDAC substrate 3 (5 mM) | BPS-50037 | 250 nmole |
| Fluorogenic HDAC class2a Substrate | BPS-50040 | 250 nmole |
|
Fluorogenic HDAC Substrate1 |
BPS-50032 |
0,5 mol |
|
|
|
|
|
|
|
|
|
Histone Deacetylase 1 (HDAC1) (human) recombinant made in Sf9 insect cells |
BPS-50001 |
50 ug |
|
Histone Deacetylase 1 (HDAC1) (human) (recombinant) (His) |
CAY-10009231-1 |
1 Vial |
|
Histone Deacetylase 2 (HDAC2) (human) recombinant made in Sf9 insect cells |
BPS-50002 |
50 ug |
|
Histone Deacetylase 2 (HDAC2) (human) (recombinant) (His) |
CAY-10009377-1 |
1 Vial |
|
Histone Deacetylase 3 (HDAC3) (human) recombinant made in Sf9 insect cells |
BPS-50003 |
50 ug |
|
Histone Deacetylase 3 (HDAC3) (human) (recombinant) (His) |
CAY-10009232-1 |
1 Vial |
| HDAC3/NCOR1 Complex (human) (recombinant) | BML-SE515 | |
|
Histone Deacetylase 4 (HDAC4) (human) recombinant made in Sf9 insect cells |
BPS-50004 |
2 ug |
|
Histone Deacetylase 5 (HDAC5) (human) recombinant made in Sf9 insect cells |
BPS-50045 |
2 ug |
|
HDAC5 full length (Histone Deacetylase 5), human rec., (made in Sf9 insect cells) |
BPS-50005 |
5 ug |
|
Histone Deacetylase 5 (HDAC5) (human) (recombinant) (His) |
CAY-10009379-1 |
1 Vial |
|
Histone Deacetylase 6 (HDAC6) (human) recombinant made in Sf9 insect cells |
BPS-50006 |
50 ug |
|
Histone Deacetylase 6 (HDAC6) (human) (recombinant) (GST) |
CAY-10009465-1 |
1 pmol |
|
Histone Deacetylase 6 (HDAC6) (human recombinant) |
CAY-10009465 |
inquire |
|
Histone Deacetylase 7 (HDAC7) (human) recombinant made in Sf9 insect cells |
BPS-50007 |
2 ug |
| Histone Deacetylase 8 (human) (recombinant) | BML-SE145 | |
|
Histone Deacetylase 8 (HDAC8) (human) recombinant made in Sf9 insect cells |
BPS-50008 |
50 ug |
|
Histone Deacetylase 8 (HDAC8) (human) (recombinant) (His) |
CAY-10009380-1 |
1 Vial |
|
Histone Deacetylase 9 (HDAC9) (human) recombinant made in Sf9 insect cells |
BPS-50009 |
5 ug |
|
Histone Deacetylase 9 (HDAC9) (human) (recombinant) (His) |
CAY-10009466-1 |
1 pmol |
|
Histone Deacetylase 9 (HDAC9) (human recombinant) |
CAY-10009466 |
inquire |
|
Histone Deacetylase 10 (HDAC10) (human) |
BPS-50010 |
50 g |
|
Histone Deacetylase 11 (HDAC11) (human) (under development) |
BPS-50011 |
50 g |
|
Histone Deacetylase (HDAC) (rat) |
ALX-202-052-L002 |
2 ml |
|
|
|
|
|
Histone Deacetylase (HDAC) Antibodies |
|
|
|
HDAC Family Antibody Set |
BV-K333-11-30 |
1 Set |
|
Monoclonal Antibody to Histone Deacetylase 1 (HDAC)(10E2), Mouse IgG1 |
ALX-804-599-C200 |
200 g |
|
Polyclonal Antibody to Histone Deacetylase 1, (HDAC1) From rabbit. |
ALX-210-256-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 1 (HDAC1) rabbit |
V13-40967 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 1, (HDAC1) From rabbit. |
ABR-PA1-860-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 1 (HDAC1), Rabbit |
ASB-ARP38530-T100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 1 (HDAC1) |
BV-3601-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 2, (HDAC2) From rabbit. |
ALX-210-257-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 2, (HDAC2 ) From rabbit. |
ABR-PA1-861-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 2, (HDAC2 ) From rabbit. |
ASB-ARP32618-P050 |
50 g |
|
Polyclonal Antibody to Histone Deacetylase 2 (HDAC2) |
BV-3602-100 |
100 g |
|
Polyclonal Antibody to Histone Deactetylase 3, (HDAC3) From rabbit. |
ALX-210-258-C100 |
100 g |
|
Polyclonal Antibody to Histone Deactetylase 3, (HDAC3) From rabbit. |
ABR-PA1-862-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 3 (HDAC3) |
BV-3603-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 3 (HDAC3) rabbit pAb |
V13-40968 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 4 (HDAC4)(human) (CT), From rabbit. |
ALX-210-338-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 4 (HDAC4)(NT), From rabbit. |
ALX-210-339-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 4 (HDAC4)(human) (CT), From rabbit. |
ABR-PA1-863-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 4 (HDAC4) |
BV-3604-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 4 (HDAC4) rabbit pAb |
V13-40969 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 4 (HDAC4) |
BV-3604A-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 5, (HDAC5) From rabbit. |
ALX-210-340-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 5 (HDAC5) |
BV-3605-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 5 (HDAC5) rabbit pAb |
V13-40970 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 6, (HDAC5) From rabbit. |
ALX-210-341-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 6 (HDAC6), Rabbit |
ASB-ARP31451-P050 |
50 g |
|
Polyclonal Antibody to Histone Deacetylase 6 (HDAC6) |
BV-3606-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 6 (HDAC6) rabbit pAb |
V13-40971 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 7 (HDAC7) |
BV-3607-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 8, (HDAC8) From rabbit. |
ASB-ARP34587-P050 |
50 g |
|
Polyclonal Antibody to Histone Deacetylase 8 (HDAC8) |
BV-3608-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 9 (HDAC9) |
BV-3609-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 10 (HDAC10) |
ABR-PA1-4289-C100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 10 (HDAC10) |
BV-3610-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 11 (HDAC11) |
BV-3611P-100 |
100 g |
|
Polyclonal Antibody to Histone Deacetylase 11 (HDAC11) rabbit pAb |
V13-39208 |
200 l |
|
|
|
|
|
Histone Deacetylase (HDAC) Assay Kits |
|
|
|
Fluor-de-Lys : Gold Standard Kits for Acetylation
Assays See our in-house developed Fluor De-Lys® assay - a versatile non-radioactive assay for measuring HDAC and sirtuin activity. The Fluor De-Lys® assay system is compatible with all three classes of HDACs. A complete range of innovative HDAC, sirtuin and HAT reagents, including enzymes, substrates, antibodies, and inhibitors are now available. |
 |
|
 |
||
| Fluor-de-Lys Histone Deacetylase (HDAC) Fluorescent Activity Assay Kit | BML-AK500 | |
| Histone Deacetylase (HDAC) Colorimetric Activity Assay Kit | BML-AK501 | |
| HDAC Fluorimetric Cellular Activity Assay Kit | BML-AK503 | |
| HDAC1 Fluorimetric Drug Discovery Kit | BML-AK511 | |
| HDAC8 Fluorimetric Drug Discovery Kit | BML-AK518 | |
| SIRT2 Fluorescent Activity Assay/Drug Discovery Kit | BML-AK556 | |
| Fluor-de-Lys | BML-KI104 | |
| Fluor-de-Lys-H4-AcK16 | BML-KI174 | |
| Fluor-de-Lys-SIRT1 | BML-KI177 | |
| Fluor-de-Lys-HDAC8 | BML-KI178 | |
| Fluor-de-Lys-SIRT2 | BML-KI179 | |
| Fluor-de-Lys Developer Concentrate | BML-KI105 | |
| Fluor-de-Lys Developer II | BML-KI176 | |
| Fluor-de-Lys Deacetylated Standard | BML-KI142 | |
|
Histone Deacetylase HDAC Colorimetric Assay Kit |
BV-K331-100 |
100 Assays |
|
|
BV-K331-1000 |
1000 Assays |
| Fluorogenic HDAC assay kit | BPS-50033 | 100 assays |
| Fluorogenic HDAC class2a assay kit 1 | BPS-50041 | 100 assays |
|
Histone Deacetylase HDAC Fluorometric Assay Kit |
BV-K330-100 |
100 Assays |
|
|
BV-K330-1000 |
1000 Assays |
|
Histone Deacetylase HDAC Inhibitor Drug Screening Kit |
BV-K340-100 |
100 Assays |
|
Histone Deacetylase HDAC Activity / Inhibitor Screening Assay Kit |
CAY-789701-KI01 |
96 wells |
|
|
|
|
|
Histone Acetyltransferase (HAT) & related products |
|
|
|
pCAF Histone Acetyltransferase (human) (rec.) (GST) |
CAY-10009115-C025 |
25 ug |
|
|
CAY-10009115-C050 |
50 ug |
|
|
CAY-10009115-C100 |
100 ug |
|
HAT Assay Kit (Fluorescent) Quickly and easily assay for histone acetyltransferase (HAT) activity or screen HAT inhibitors with our new simple and sensitive fluorescent HAT assay kit. Fast 30-minute assay The histone acetyltransferase assay kit is a fluorescent method to assay samples for histone acetyltransferase (HAT) activity or to screen HAT inhibitors. The assay is easy to use, features a simple protocol that gives you results in 30 minutes and is ideal for high-throughput usage in 96-well plates. |
V13-56100 |
1 x 96 rxns |
|
HAT Activity Assay Kit Histone acetyltransferases (HATs) have been implicated to play a crucial role in various cellular functions, such as gene transcription, differentiation, and proliferation. BioVisions HAT Activity Colorimetric Assay Kit offers a convenient, nonradioactive system for a rapid and sensitive detection of HAT activity in mammalian samples. The kit utilizes active recombinant HAT as a positive control and acetyl-CoA as a cofactor. Acetylation of peptide substrate by active HAT releases the free form of CoA which then serves as an essential coenzyme for producing NADH. NADH can easily be detected spectrophotometrically upon reacting with a soluble tetrazolium dye. The detection can be continuous and suitable for kinetic studies. The kit provides a simple, straightforward protocol for a complete assay. |
BV-K332-100 |
100 Assays |
|
HAT Inhibitor Screening Assay Kit |
CAY-10006515 |
96 wells |
|
Histones |
|
|
|
Histone H1-7 Substrate |
ALX-158-001-M001 |
1 mg |
|
|
ALX-158-001-M005 |
5 mg |
|
Histone (calf thymus) |
ALX-202-057-M010 |
10 mg |
|
Histone H1 (calf thymus) |
ALX-202-029-M001 |
1 mg |
|
Histone H1 (calf thymus) |
ALX-202-029-M005 |
5 mg |
|
Histone H1.0 (human) (recombinant) |
ALX-201-156-M001 |
1 mg |
|
Histone H1.0 (human) (recombinant) |
ALX-201-156-M005 |
5 mg |
|
Histone H1.2 (human) (recombinant) |
ALX-201-160-M001 |
1 mg |
|
Histone H1.2 (human) (recombinant) |
ALX-201-160-M005 |
5 mg |
|
Histone H1.3 (human) (recombinant) |
ALX-201-157-M001 |
1 mg |
|
Histone H1.3 (human) (recombinant) |
ALX-201-157-M005 |
5 mg |
|
Histone H1.4 (human) (recombinant) |
ALX-201-158-M001 |
1 mg |
|
Histone H1.4 (human) (recombinant) |
ALX-201-158-M005 |
5 mg |
|
Histone H1.5 (human) (recombinant) |
ALX-201-159-M001 |
1 mg |
|
Histone H1.5 (human) (recombinant) |
ALX-201-159-M005 |
5 mg |
|
Histone gamma-H2AX (human) (recombinant) |
ALX-201-176-M001 |
1 mg |
|
Histone gamma-H2AX (human) (recombinant) |
ALX-201-176-M005 |
5 mg |
|
[Ala32]-Histone H2B (29-35) |
ALX-158-002-M001 |
1 mg |
|
[Ala32]-Histone H2B (29-35) |
ALX-158-002-M005 |
5 mg |
|
Histone H2B (29-35) |
ALX-158-003-M001 |
1 mg |
|
Histone H2B (29-35) |
ALX-158-003-M005 |
5 mg |
|
[Ala34]-Histone H2B (29-35) |
ALX-158-004-M001 |
1 mg |
|
[Ala34]-Histone H2B (29-35) |
ALX-158-004-M005 |
5 mg |
|
|
|
|
|
Antibodies to Histones |
|
|
|
Monoclonal Antibody to Histone gamma-H2AX (phosphorylated) (pSer139) (3F2) |
ABR-MA1-2022-C100 |
100 g |
|
Monoclonal Antibody to Histone H3 (phosphorylated) (made in mouse) |
V13-39211 |
100 g |
|
Polyclonal Antibody to Histone gamma-H2AX (human) (phosphorylated) (pSer139) |
ALX-210-390-R050 |
50 l |
|
Polyclonal Antibody to Histone H2AX |
BV-3761-100 |
100 ul |
|
Polyclonal Antibody to Histone H2A |
BV-3621-100 |
100 ug |
|
Polyclonal Antibody to Histone H2A rabbit pAb |
V13-39209 |
100 g |
|
Polyclonal Antibody to Histone H2B rabbit pAb |
V13-39210 |
100 g |
|
Polyclonal Antibody to Histone H2B |
BV-3622-100 |
100 ug |
|
Polyclonal Antibody to Acetyl-Histone H2A |
BV-3653-100 |
100 ug |
|
Polyclonal Antibody to Acetyl-Histone H2B |
BV-3654-100 |
100 ug |
|
Polyclonal Antibody to Histone H3 rabbit pAb |
V13-39088 |
100 g |
|
Polyclonal Antibody to Histone H3 |
BV-3623-100 |
100 ug |
|
Polyclonal Antibody to Acetyl-Histone H3 |
BV-3655-100 |
100 ug |
|
Polyclonal Antibody to Histone H3 (human) (NT) (dimethylated Lys9) |
CVL-PAB0189-1 |
1 Vial |
|
Polyclonal Antibody to Histone H4 |
BV-3624-100 |
100 ug |
|
Polyclonal Antibody to Histone H4 rabbit pAb |
V13-39212 |
100 g |
|
Polyclonal Antibody to Acetyl-Histone H4 |
BV-3656-100 |
100 ug |
|
Other Products |
|
|
| p300 (human) (recombinant) | JBS-PR-762 | 2 g |
| Recombinant p300 protein | V13-31124 | 4 g |
| p300 (C-terminal Domain) (human) (recombinant) | JBS-PR-770 | 4 g |
| p300 mouse mAb (32010125) | V13-39519 | 100 l |
| Sirtuin 1, human rec., (made in E.coli) | BPS-50012 | 100 g |
| Sirtuin 2, human rec., (made in E.coli) | BPS-50013 | 100 g |
| Sirtuin 3, human rec., (made in E.coli) | BPS-50014 | 100 g |
| Sirtuin 4 , human rec., (made in E.coli) | BPS-50015 | 100 g |
| Sirtuin 5, human rec., (made in E.coli) | BPS-50016 | 100 g |
| Polyclonal Antibody to p300 (human), From rabbit. | ABR-PA1-848-C100 | 100 g |
| Polyclonal Antibody to p300 (human), From rabbit. | ALX-210-228-C100 | 100 g |
|
|
||
|
Blocking Peptides |
|
|
|
Blocking Peptide for PAb to Histone Deacetylase 1 (Prod. No. ALX-210-256) |
ALX-158-006-C050 |
50 g |
|
Blocking Peptide for PAb to Histone Deacetylase 1 [HDAC1] (BV-3601) |
BV-3601BP-50 |
50 ug |
|
Blocking Peptide for PAb to Histone Deacetylase 2 (Prod. No. ALX-210-257) |
ALX-158-007-C050 |
50 g |
|
Blocking Peptide for PAb to Histone Deacetylase 2 [HDAC2] (BV-3602) |
BV-3602BP-50 |
50 ug |
|
Blocking Peptide for PAb to Histone Deacetylase 3 (Prod. No. ALX-210-258) |
ALX-158-008-C050 |
50 g |
|
Blocking Peptide for PAb to Histone Deacetylase 3 [HDAC3] (BV-3603) |
BV-3603BP-50 |
50 ug |
|
Blocking Peptide for PAb to Histone Deacetylase 4 (human) (CT) (Prod. No. ALX-210-338) |
ALX-158-009-C050 |
50 g |
|
Blocking Peptide for PAb to Histone Deacetylase 4 [HDAC4] (BV-3604) |
BV-3604BP-50 |
50 ug |
|
Blocking Peptide for PAb to Histone Deacetylase 5 [HDAC5] (BV-3605) |
BV-3605BP-50 |
50 ug |
|
Blocking Peptide for PAb to Histone Deacetylase 6 [HDAC6] (BV-3606) |
BV-3606BP-50 |
50 ug |
|
Blocking Peptide for PAb to Histone Deacetylase 7 [HDAC7] (BV-3607) |
BV-3607BP-50 |
50 ug |
|
Blocking Peptide for PAb to Histone Deacetylase 8 [HDAC-8] (BV-3608) |
BV-3608BP-50 |
50 ug |
|
Blocking Peptide for PAb to Histone Deacetylase 9 [HDAC9] (BV-3609) |
BV-3609BP-50 |
50 ug |
|
Blocking Peptide for PAb to Histone Deacetylase 10 [HDAC10] (BV-3610) |
BV-3610BP-50 |
50 ug |
|
Blocking Peptide for PAb to Histone Deacetylase 11 [HDAC11] (BV-3611P) |
Bv-3611BP-50 |
50 ug |
|
|
Vinci-Biochem - Via Ponte di Bagnolo,
10 PRODOTTI ESCLUSIVAMENTE PER RICERCA, NON PER USO SULL'UOMO, NON PER USO DIAGNOSTICO SE NON DIVERSAMENTE SPECIFICATO ALL OUR PRODUCTS ARE FOR RESEARCH USE ONLY, IF NOT OTHERWISE SPECIFIED
Copyright ©2011 Vinci-Biochem
|
Vinci-Biochem - Via Ponte di Bagnolo,
10 PRODOTTI ESCLUSIVAMENTE PER RICERCA, NON PER USO SULL'UOMO, NON PER USO DIAGNOSTICO SE NON DIVERSAMENTE SPECIFICATO ALL OUR PRODUCTS ARE FOR RESEARCH USE ONLY, IF NOT OTHERWISE SPECIFIED
Copyright ©2011 Vinci-Biochem
|
Vinci-Biochem - Via Ponte di Bagnolo,
10 PRODOTTI ESCLUSIVAMENTE PER RICERCA, NON PER USO SULL'UOMO, NON PER USO DIAGNOSTICO SE NON DIVERSAMENTE SPECIFICATO ALL OUR PRODUCTS ARE FOR RESEARCH USE ONLY, IF NOT OTHERWISE SPECIFIED
Copyright ©2011 Vinci-Biochem
|
|
|